Aurobindo Pharma Ltd.
|
QUARTERLY RESULTS
|
|
You can view the
Quaterly Results
for the last 5 years.
Market Cap. (Rs.)
|
63518.67 Cr.
|
P/BV
|
2.37
|
Book Value (Rs.)
|
458.07
|
52 Week High/Low (Rs.)
|
1177/581
|
FV/ML
|
1/1
|
P/E(X)
|
32.95
|
Bookclosure
|
20/02/2024
|
EPS (Rs.)
|
32.90
|
Div Yield (%)
|
0.28
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 7271.23 | 7150.71 | 6790.64 | 6378.67 | 6387.97 |
Other Operating Income | 80.55 | 68.71 | 59.88 | 94.29 | 19.16 |
Total Income From Operations | 7351.78 | 7219.42 | 6850.52 | 6472.96 | 6407.13 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 2675.52 | 2708.91 | 2756.83 | 2670.57 | 2621.49 |
Purchase of Traded Goods | 775.75 | 631.07 | 580.16 | 588.75 | 537.95 |
Increase/Decrease in Stocks | -300.70 | -103.24 | -182.28 | -328.35 | -251.88 |
Employees Cost | 989.68 | 954.97 | 951.97 | 851.90 | 921.72 |
Depreciation | 423.27 | 417.50 | 326.56 | 345.57 | 321.40 |
Other Expenses | 1610.22 | 1654.27 | 1592.47 | 1687.91 | 1623.44 |
Total Expenses | 6173.74 | 6263.48 | 6025.71 | 5816.35 | 5774.12 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 1178.04 | 955.94 | 824.81 | 656.61 | 633.01 |
Other Income | 162.52 | 186.98 | 116.33 | 134.91 | 92.65 |
P/L Before Interest, Excpt. Items & Tax | 1340.56 | 1142.92 | 941.14 | 791.52 | 725.66 |
Interest | 75.55 | 68.18 | 56.55 | 55.60 | 44.96 |
P/L Before Exceptional Items & Tax | 1265.01 | 1074.74 | 884.59 | 735.92 | 680.70 |
Exceptional Items | 0.00 | 0.00 | -69.75 | 0.00 | 0.00 |
P/L Before Tax | 1265.01 | 1074.74 | 814.84 | 735.92 | 680.70 |
Tax | 322.45 | 323.70 | 242.32 | 224.15 | 189.10 |
P/L After Tax from Ordinary Activities | 942.56 | 751.04 | 572.52 | 511.77 | 491.60 |
Net Profit/Loss For the Period | 942.56 | 751.04 | 572.52 | 511.77 | 491.60 |
Minority Interest | -3.68 | 5.24 | 1.04 | 0.36 | 0.25 |
Share Of P/L Of Associates | -2.59 | 0.90 | -2.81 | -5.86 | -0.59 |
Net P/L After Minority Interest & Share Of Associates | 936.29 | 757.18 | 570.75 | 506.27 | 491.26 |
| | | | | |
Equity Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 16.04 | 12.83 | 9.74 | 8.64 | 8.38 |
Diluted EPS (Rs.) | 16.04 | 12.83 | 9.74 | 8.64 | 8.38 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 16.04 | 12.83 | 9.74 | 8.64 | 8.38 |
Diluted EPS (Rs.) | 16.04 | 12.83 | 9.74 | 8.64 | 8.38 |
| | | | | |
PBITOE Margin (%) | 16.02 | 13.24 | 12.04 | 10.14 | 9.87 |
PBTE Margin (%) | 17.20 | 14.88 | 12.91 | 11.36 | 10.62 |
PBT Margin (%) | 17.20 | 14.88 | 11.89 | 11.36 | 10.62 |
PAT Margin (%) | 12.82 | 10.40 | 8.35 | 7.90 | 7.67 |
PAT After MI And SOA Margin (%) | 12.73 | 10.48 | 8.33 | 7.82 | 7.66 |